{"id":11416,"date":"2025-07-26T19:59:51","date_gmt":"2025-07-26T17:59:51","guid":{"rendered":"https:\/\/valintermed.com\/?p=11416"},"modified":"2025-07-26T19:59:51","modified_gmt":"2025-07-26T17:59:51","slug":"sindrom-giyena-barre","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/hypoxia-syndrome\/","title":{"rendered":"Guillain-Barre syndrome"},"content":{"rendered":"
<\/div>\n

Guillain-Barr\u00e9 syndrome (GBS) is an acute inflammatory disease of the peripheral nervous system characterized by the body's immune response to infectious agents, which leads to demyelination of the myelin sheaths of nerve fibers. An important aspect of this syndrome is its exudative course, followed by the development of muscle weakness, paralysis and sensory disturbances. GBS can progress rapidly, leading to general weakness and even respiratory failure. The disease most often develops after viral or bacterial infections, such as influenza, cytomegalovirus, and rarely, but can be associated with vaccination. Understanding the mechanisms of pathogenesis and clinical manifestations of the syndrome is key to timely diagnosis and treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n